Lemtrada (Alemtuzumab Injection) is a CD52-directed cytolytic monoclonal antibody used for the treatment of relapsing forms of multiple sclerosis (MS). Due to its specific safety and risk management requirements, strict regulations must be followed for its purchase and use.
How to Purchase Lemtrada (Alemtuzumab Injection)
Overseas Purchase
Patients may choose to consult and purchase Lemtrada at hospital pharmacies or legitimate drugstores in countries or regions where the injection has been launched.
Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan in advance before purchasing.
Purchase Through Medical Service Institutions
Patients may consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.
These institutions can usually provide legal import channels and offer professional consultation and guidance.
Precautions for Purchasing Lemtrada (Alemtuzumab Injection)
Essential Examinations Before Medication Use
Laboratory tests: Include baseline examinations such as complete blood count, serum creatinine, and thyroid function.
Infection screening: Rule out active infections (e.g., HIV, tuberculosis, hepatitis B/hepatitis C) and check vaccination history (which should be completed 6 weeks before medication use).
Contraindicated Populations
Patients allergic to alemtuzumab or its excipients.
Patients with active infections or HIV infection.
Pregnant women (may cause fetal harm) and women of childbearing age who have not taken contraceptive measures.
Long-Term Monitoring Requirements
Continuous follow-up monitoring for 48 months is required after medication administration.
Monthly: Complete blood count, urine routine, and renal function tests.
Every 3 months: Thyroid function tests.
Annually: Skin cancer screening (especially for melanoma).
How to Identify Authentic vs. Counterfeit Lemtrada (Alemtuzumab Injection)
Characteristics of Packaging and Labels
Specification: Each vial contains 12mg/1.2mL (10mg/mL) of the drug. It is supplied in a single-dose clear glass vial, and the solution is colorless to slightly yellow.
Markings: The outer packaging should be printed with the "LEMTRADA®" trademark, information about Genzyme Corporation, and the U.S. FDA approval number.
Anti-counterfeiting code: Verify the drug batch number and expiration date through official channels.
Channel Verification
Limited to legitimate medical centers: Query certified institutions through the official LEMTRADA REMS website.
